This is what happens when no-one is prepared to sell down, punters have to pay up.
Still seriously undervalued imo.
Dr Crombie stated himself the only biotech on the ASX with a comparable pipeline of clinical trials is Mesoblast, and their market cap is over $1 Billion !
VIDEO - Aktivate acquisition - Rob Crombie, page-17
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
